A Family Affair

Selective Reaction Careful choice of reagents leads to bromination of a protected resveratrol dimer in either of two places (red and green arrows).

A strategy from chemists at Columbia University has enabled the first syntheses of several members of a structurally intricate family of oligomeric compounds derived from the red wine compound resveratrol (Nature, DOI: 10.1038/nature10197). The team says their work could be applied to multiple classes of compounds.

Plant species worldwide make oligomers of resveratrol to fend off fungal infections, and some of these compounds have promising anticancer and anti-HIV activity. Only small quantities can be obtained from natural sources. And they're a thorny synthetic challenge because resveratrol can connect to itself in myriad ways, whereas units of other natural product oligomers, such as terpenes, typically link to one another in only one or two ways.

Starting from resveratrol dimers they synthesized previously, Scott A. Snyder and coworkers use regioselective bromination reactions to selectively construct resveratrol trimers and tetramers, the highest-order resveratrol oligomers prepared yet. One of the brominations was mediated by a reagent the Snyder team developed earlier.

Snyder uses "exquisite chemistry" to generate the oligomers, but it's not clear that the work brings practical applications for the resveratrol family any closer, says John Pezzuto of the University of Hawaii, Hilo, a pioneer in studying resveratrol's pharmacology. Large polyphenols have traditionally been excluded in drug discovery programs, he says. "Of course, many things with little or no obvious practical value enrich our lives in a variety of ways," he adds. "So until demonstrated otherwise, the artistry of this work should be sufficient to satiate our curiosity."

Resveratrol may have been the subject of intense media and scientific scrutiny, even hype, but it has catalyzed new research on caloric restriction and the aging process, Snyder says. "I like to think of natural products as leading us into new areas of biochemical research, so even if they don't become drugs, they're of value."

Chemical & Engineering News

ISSN 0009-2347

Copyright © 2011 American Chemical Society